Blocking HMGB1/RAGE Signaling by Berberine Alleviates A1 Astrocyte and Attenuates Sepsis-Associated Encephalopathy

As a life-threatening multiple organ dysfunction attributable to maladjusted host immune responses to infection, sepsis is usually the common pathway to serious prognosis and death for numerous infectious diseases all over the world. Sepsis-associated encephalopathy (SAE) is frequently complicated b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jian Shi, Huan Xu, María José Cavagnaro, Xingmei Li, Jia Fang
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/dc941ff61a674ed7b05176ef9904331b
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:dc941ff61a674ed7b05176ef9904331b
record_format dspace
spelling oai:doaj.org-article:dc941ff61a674ed7b05176ef9904331b2021-11-15T05:57:58ZBlocking HMGB1/RAGE Signaling by Berberine Alleviates A1 Astrocyte and Attenuates Sepsis-Associated Encephalopathy1663-981210.3389/fphar.2021.760186https://doaj.org/article/dc941ff61a674ed7b05176ef9904331b2021-11-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.760186/fullhttps://doaj.org/toc/1663-9812As a life-threatening multiple organ dysfunction attributable to maladjusted host immune responses to infection, sepsis is usually the common pathway to serious prognosis and death for numerous infectious diseases all over the world. Sepsis-associated encephalopathy (SAE) is frequently complicated by septic conditions, and is one of the most important reasons for increased mortality and poor outcomes in septic patients which is still an urgent clinical problem need to be solved. In this research, a conspicuously discovery of treatment-related translational use for berberine was elaborated. The results revealed that berberine treatment significantly restored cognitive impairment in sepsis mice. Reduced expression levels of TNF-α, IL-1α, and C1qA were exhibited in the hippocampus of the berberine treatment group, and attenuated effect of declining neo-neuron, activation of microglia and astrocytes in the hippocampus of mice with sepsis were also found. Moreover, berberine inhibits microglia-stressed A1 astrocytes by inhibiting HMGB1 signaling was revealed, then the molecular mechanism of HMGB1/RAGE signaling inhibition leads to the better outcome of SAE was elucidated. To summarize, this research indicated that berberine targets HMGB1/RAGE signaling to inhibit microglia-stressed A1 astrocyte and neo-neuron decline, which consequently alleviates sepsis-induced cognitive impairment. Collectively, berberine may serve as potential therapeutic drug and HMGB1/RAGE signaling would be a novel target for medicine development for treating SAE.Jian ShiJian ShiHuan XuMaría José CavagnaroXingmei LiXingmei LiJia FangFrontiers Media S.A.articleberberinesepsis-associated encephalopathyHMGB1/RAGE signalingcognitive impairmentinflammatory cytokinesneuropharmacologyTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic berberine
sepsis-associated encephalopathy
HMGB1/RAGE signaling
cognitive impairment
inflammatory cytokines
neuropharmacology
Therapeutics. Pharmacology
RM1-950
spellingShingle berberine
sepsis-associated encephalopathy
HMGB1/RAGE signaling
cognitive impairment
inflammatory cytokines
neuropharmacology
Therapeutics. Pharmacology
RM1-950
Jian Shi
Jian Shi
Huan Xu
María José Cavagnaro
Xingmei Li
Xingmei Li
Jia Fang
Blocking HMGB1/RAGE Signaling by Berberine Alleviates A1 Astrocyte and Attenuates Sepsis-Associated Encephalopathy
description As a life-threatening multiple organ dysfunction attributable to maladjusted host immune responses to infection, sepsis is usually the common pathway to serious prognosis and death for numerous infectious diseases all over the world. Sepsis-associated encephalopathy (SAE) is frequently complicated by septic conditions, and is one of the most important reasons for increased mortality and poor outcomes in septic patients which is still an urgent clinical problem need to be solved. In this research, a conspicuously discovery of treatment-related translational use for berberine was elaborated. The results revealed that berberine treatment significantly restored cognitive impairment in sepsis mice. Reduced expression levels of TNF-α, IL-1α, and C1qA were exhibited in the hippocampus of the berberine treatment group, and attenuated effect of declining neo-neuron, activation of microglia and astrocytes in the hippocampus of mice with sepsis were also found. Moreover, berberine inhibits microglia-stressed A1 astrocytes by inhibiting HMGB1 signaling was revealed, then the molecular mechanism of HMGB1/RAGE signaling inhibition leads to the better outcome of SAE was elucidated. To summarize, this research indicated that berberine targets HMGB1/RAGE signaling to inhibit microglia-stressed A1 astrocyte and neo-neuron decline, which consequently alleviates sepsis-induced cognitive impairment. Collectively, berberine may serve as potential therapeutic drug and HMGB1/RAGE signaling would be a novel target for medicine development for treating SAE.
format article
author Jian Shi
Jian Shi
Huan Xu
María José Cavagnaro
Xingmei Li
Xingmei Li
Jia Fang
author_facet Jian Shi
Jian Shi
Huan Xu
María José Cavagnaro
Xingmei Li
Xingmei Li
Jia Fang
author_sort Jian Shi
title Blocking HMGB1/RAGE Signaling by Berberine Alleviates A1 Astrocyte and Attenuates Sepsis-Associated Encephalopathy
title_short Blocking HMGB1/RAGE Signaling by Berberine Alleviates A1 Astrocyte and Attenuates Sepsis-Associated Encephalopathy
title_full Blocking HMGB1/RAGE Signaling by Berberine Alleviates A1 Astrocyte and Attenuates Sepsis-Associated Encephalopathy
title_fullStr Blocking HMGB1/RAGE Signaling by Berberine Alleviates A1 Astrocyte and Attenuates Sepsis-Associated Encephalopathy
title_full_unstemmed Blocking HMGB1/RAGE Signaling by Berberine Alleviates A1 Astrocyte and Attenuates Sepsis-Associated Encephalopathy
title_sort blocking hmgb1/rage signaling by berberine alleviates a1 astrocyte and attenuates sepsis-associated encephalopathy
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/dc941ff61a674ed7b05176ef9904331b
work_keys_str_mv AT jianshi blockinghmgb1ragesignalingbyberberinealleviatesa1astrocyteandattenuatessepsisassociatedencephalopathy
AT jianshi blockinghmgb1ragesignalingbyberberinealleviatesa1astrocyteandattenuatessepsisassociatedencephalopathy
AT huanxu blockinghmgb1ragesignalingbyberberinealleviatesa1astrocyteandattenuatessepsisassociatedencephalopathy
AT mariajosecavagnaro blockinghmgb1ragesignalingbyberberinealleviatesa1astrocyteandattenuatessepsisassociatedencephalopathy
AT xingmeili blockinghmgb1ragesignalingbyberberinealleviatesa1astrocyteandattenuatessepsisassociatedencephalopathy
AT xingmeili blockinghmgb1ragesignalingbyberberinealleviatesa1astrocyteandattenuatessepsisassociatedencephalopathy
AT jiafang blockinghmgb1ragesignalingbyberberinealleviatesa1astrocyteandattenuatessepsisassociatedencephalopathy
_version_ 1718428586923261952